Table 1.
Patients and tumor characteristics.
| Number of Patients | 25 | ||
| Sex | |||
| Male | 18 | (72%) | |
| Female | 7 | (28%) | |
| Age | |||
| Median (range) in years | 65 | (37–82) | |
| <60 years | 5 | (20%) | |
| 60–65 years | 11 | (44%) | |
| >65 years | 9 | (36%) | |
| KPS Score | |||
| Median (range), in % | 60 | (50–90) | |
| <60% | 5 | (20%) | |
| 60–70% | 16 | (64%) | |
| >70% | 4 | (16%) | |
| RPA Class | |||
| Median (range) | V | (IV–VI) | |
| IV | 7 | (28%) | |
| V | 10 | (40%) | |
| VI | 8 | (32%) | |
| CCI | |||
| Median (range) | 8 | (5–14) | |
| <7 | 6 | (24%) | |
| 7–9 | 18 | (72%) | |
| >9 | 2 | (4%) | |
| Mass Effect | |||
| Yes | 15 | (60%) | |
| No | 10 | (40%) | |
| Surgery | |||
| Complete | 3 | (12%) | |
| Incomplete | 12 | (48%) | |
| Unresectable (biopsy) | 10 | (40%) | |
| Multifocal Tumor | |||
| Yes | 7 | (28%) | |
| No | 18 | (72%) | |
| Poor Molecular Factors | |||
| wild-type IDH | 25 | (100%) | |
| Unmethylated MGMT | 19 | (76%) | |
| Gross Tumor Volume | |||
| Median (range), in cc | 50 | (31–135) | |
| ≤50 cc | 16 | (64%) | |
| >50 cc | 9 | (36%) | |
| Planning Target Volume | |||
| Median (range), in cc | 220 | (117–358) | |
| ≤200 cc | 12 | (48%) | |
| >200 cc | 13 | (52%) |